Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-21

Clinical Trial Update: The Efficacy and Safety of Puerarin in Obesity Treatment [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating the efficacy and safety of puerarin for obesity. The study is not yet recruiting and is sponsored by R…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Puerarin (puerarin)

Snippet

Sponsor: Ruijin Hospital | Conditions: Metabolic Diseases, Obesity/Therapy | Phase 2 | Status: NOT_YET_RECRUITING